Loughborough, United Kingdom

David O'Sullivan

This inventor holds 2 USPTO granted patents. Top assignees: Astrazeneca Ab, Argenta Discovery Limited. Active years: 2010-2012.

IDiyas Innovation Intelligence. (2026). Inventor Profile: David O'Sullivan. Retrieved from https://idiyas.com/inventor/david-o-sullivan-bv9yk4wn

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 3.4

ph-index = 1


Location History:

  • Loughborough, GB (2010)
  • Leicestershire, GB (2012)

Company Filing History:


Years Active: 2010-2012

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations and Contributions of Inventor David O'Sullivan

Introduction

David O'Sullivan, an inventive mind located in Loughborough, Great Britain, has made significant strides in the field of pharmaceuticals, holding two patents to his name. His work primarily revolves around compounds that hold promise for the treatment of various diseases, showcasing his commitment to innovation in healthcare.

Latest Patents

O'Sullivan's latest patents highlight his expertise and inventive nature. The first patent involves Piperidine derivatives, which introduces a compound defined by a specific formula aimed at treating chemokine mediated diseases, particularly targeting the CCR3 receptor. This advancement underscores his dedication to developing effective therapeutic options. The second patent presents a novel pharmaceutical compound, specifically [2-(4-chloro-benzyloxy)-ethyl]-[2-((R)-cyclohexyl-hydroxy-phenyl-methyl)-oxazol-5-yl-methyl]-dimethyl-ammonium napadisylate. This invention also includes pharmaceutical compositions that utilize the compound, further indicating its relevance in contemporary medical therapies.

Career Highlights

Throughout his career, O'Sullivan has been associated with notable companies such as AstraZeneca and Argenta Discovery Limited. His work in these esteemed organizations has undoubtedly contributed to the development of pharmaceutical innovations and has facilitated his professional growth as an inventor.

Collaborations

David O'Sullivan has collaborated with distinguished professionals in his field, including Barbara Giuseppina Avitabile and Richard James Bull. These collaborations reflect his ability to work alongside other experts to foster innovation and drive impactful research.

Conclusion

David O'Sullivan's contributions to pharmaceutical inventions through his patents and collaborations mark him as a valuable figure in the landscape of innovation. His commitment to developing new therapeutic compounds underscores the importance of research and creativity in the medical field, offering hope for advancing healthcare solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…